Cost-effectiveness of programmed cell death ligand 1 testing and tumor mutational burden testing of immune checkpoint inhibitors for advanced non-small cell lung cancer

Affiliations

Wen-Qian Li: Department of Cancer Center, The First Hospital of Jilin University, Changchun, Jilin 130021, China.
Ling-Yu Li: Department of Cancer Center, The First Hospital of Jilin University, Changchun, Jilin 130021, China.
Ri-Lan Bai: Department of Cancer Center, The First Hospital of Jilin University, Changchun, Jilin 130021, China.
Lei Qian: Department of Cancer Center, The First Hospital of Jilin University, Changchun, Jilin 130021, China.
Nai-Fei Chen: Department of Cancer Center, The First Hospital of Jilin University, Changchun, Jilin 130021, China.
Jiu-Wei Cui: Department of Cancer Center, The First Hospital of Jilin University, Changchun, Jilin 130021, China.
Ning-Ning Wang: Department of Cancer Center, The First Hospital of Jilin University, Changchun, Jilin 130021, China.

Abstract

No abstracts available.